Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash and Demand Deposits in the U.S.
QFR201385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
70,548.00
Year-over-Year Change
20.43%
Date Range
10/1/2000 - 1/1/2025
Summary
Captures cash and demand deposit levels for U.S. pharmaceutical and medicine corporations. Critical indicator of financial liquidity in the healthcare manufacturing sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
This quarterly financial metric tracks cash reserves for pharmaceutical companies. Provides insights into sector-wide financial capabilities and strategic positioning.
Methodology
Compiled through comprehensive corporate financial reporting and Federal Reserve surveys.
Historical Context
Utilized by investors, analysts, and policymakers to evaluate pharmaceutical industry financial health.
Key Facts
- Quarterly reporting frequency
- Includes U.S. bank deposits
- Reflects pharmaceutical sector financial strategy
FAQs
Q: What does this financial metric represent?
A: Shows total cash and demand deposits for U.S. pharmaceutical corporations. Indicates financial readiness and investment potential.
Q: How frequently is this data updated?
A: Reported quarterly, providing current insights into pharmaceutical company cash positions.
Q: Why is cash on hand crucial for pharmaceutical companies?
A: Enables research investment, drug development, and provides financial stability during market fluctuations.
Q: How can investors interpret this data?
A: Assess financial strength and potential for research, development, and strategic acquisitions in the pharmaceutical sector.
Q: What are the potential limitations of this metric?
A: Represents a specific point in time. Should be analyzed with other financial and industry indicators.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Foundries: Interest Expense
QFR105331USNO
Quarterly Financial Report: U.S. Corporations: All Other Retail Trade: Cash Dividends Charged to Retained Earnings This Quarter
QFR120OTRUSNO
Quarterly Financial Report: U.S. Corporations: Nonmetallic Mineral Products: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319327USNO
Quarterly Financial Report: U.S. Corporations: Motor Vehicles and Parts: Interest Expense
QFR105376USNO
Quarterly Financial Report: U.S. Corporations: Computer and Peripheral Equipment: Income (Loss) Before Income Taxes
QFR111374USNO
Quarterly Financial Report: U.S. Corporations: All Durable Manufacturing: Other Short-Term Financial Investments
QFRD210DURUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: Pharmaceuticals Corporations (QFR201385USNO), retrieved from FRED.